Covid-19 Man­u­fac­tur­ing Roundup: Ther­mo Fish­er plant ramps up As­traZeneca vac­cine pro­duc­tion; No­vavax ex­pands Ko­re­an man­u­fac­tur­ing pact

Short­ly af­ter Ther­mo Fish­er’s $878.2 mil­lion buy­out of No­vasep’s vi­ral vec­tor man­u­fac­tur­ing busi­ness, it took over a plant in Bel­gium tasked with pro­duc­ing ade­n­ovirus …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER